OpenAlex
PricingAboutJobs
Log inGet started
Work

A safety and pharmacokinetic study of intravenous natalizumab in patients with MS

HTML

Year: 1999
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Neurology
DOI: 10.1212/wnl.52.5.1072
Authors: W.A. Sheremata, T.L. Vollmer, L.A. Stone, A.J. Willmer-Hulme, M. Koller
Institutions: Mayo Clinic, University of Miami, American Academy of Neurology, Yale University, Mayo Clinic in Arizona, Elan Pharmaceuticals, Inc. (Ireland)
Language: English

Topic: Multiple Sclerosis Research Studies
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: natalizumab, multiple sclerosis, relapsing-remitting multiple sclerosis, secondary progressive multiple sclerosis, intravenous administration, pharmacokinetics, drug safety, tolerability, dose escalation, serum drug concentration
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2086344593
FWCI: 1.586
Cites: 10
Cited by: 135
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security